Skip to main content
. 2014 Jun 24;16(3):R67. doi: 10.1186/bcr3682

Figure 5.

Figure 5

Caspase 3/7 activity and cell cycle distribution of 92 J isogenic cell lines upon lestaurtinib and/or AG14361 treatment. (A, B) Percentage of caspase 3/7 activity in 92 J isogenic pair of cells after they were incubated with IC50 of lestaurtinib and/or AG14361 in a time-dependent manner. (C, D) Distribution of 92 J isogenic pair of cells after they were treated with IC50 of AG14361 and/or lestaurtinib per 12, 24, 36 and 48 hr. There was no difference in the results between the two isogenic cell lines. IC50, 50% inhibition dose.